Research progress on the diagnostic value of fecal calprotectin in colorectal tumors

Fecal Calprotectin (FC), a calcium-binding protein secreted by neutrophils and macrophages and belonging to the S100 protein family, has gained increasing utilization in recent years for the diagnosis and monitoring of intestinal diseases due to its high expression and stability in inflammatory resp...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Jing, Jiangshan Sun, Qingzheng Wu, Xiuli Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1626197/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849744430728216576
author Wei Jing
Wei Jing
Jiangshan Sun
Jiangshan Sun
Qingzheng Wu
Xiuli Zhang
author_facet Wei Jing
Wei Jing
Jiangshan Sun
Jiangshan Sun
Qingzheng Wu
Xiuli Zhang
author_sort Wei Jing
collection DOAJ
description Fecal Calprotectin (FC), a calcium-binding protein secreted by neutrophils and macrophages and belonging to the S100 protein family, has gained increasing utilization in recent years for the diagnosis and monitoring of intestinal diseases due to its high expression and stability in inflammatory responses. In the field of colorectal tumors, the diagnostic value of FC has gradually emerged. Within colorectal tumors, colorectal cancer (CRC) is an area of significant research focus. Studies have demonstrated significantly elevated FC levels in patients with CRC, a phenomenon potentially linked to chronic inflammation and immune cell infiltration within the tumor microenvironment. FC exhibits notable advantages in colorectal tumor diagnosis, characterized by high sensitivity and moderate specificity. Emerging research has revealed correlations between FC levels and colorectal tumors staging as well as left-sided versus right-sided tumor localization, with elevated FC levels associated with malignant transformation, local inflammation, and advanced tumor stages (T3 and T4). The diagnostic performance of fecal calprotectin (FC) as a non-invasive marker for colorectal tumors has not yet been established. However, due to its association with inflammation, FC holds promise for playing a more significant role in the screening, staging, and localization of colorectal tumors.
format Article
id doaj-art-c91af83b971943688bc18decccb00e90
institution DOAJ
issn 2296-858X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-c91af83b971943688bc18decccb00e902025-08-20T03:17:24ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-07-011210.3389/fmed.2025.16261971626197Research progress on the diagnostic value of fecal calprotectin in colorectal tumorsWei Jing0Wei Jing1Jiangshan Sun2Jiangshan Sun3Qingzheng Wu4Xiuli Zhang5Microbiota Division, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, Beijing, ChinaSchool of Medicine, Nankai University, Tianjin, ChinaMicrobiota Division, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, Beijing, ChinaSchool of Medicine, Nankai University, Tianjin, ChinaDepartment of Endocrinology, The First Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, Beijing, ChinaMicrobiota Division, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, Beijing, ChinaFecal Calprotectin (FC), a calcium-binding protein secreted by neutrophils and macrophages and belonging to the S100 protein family, has gained increasing utilization in recent years for the diagnosis and monitoring of intestinal diseases due to its high expression and stability in inflammatory responses. In the field of colorectal tumors, the diagnostic value of FC has gradually emerged. Within colorectal tumors, colorectal cancer (CRC) is an area of significant research focus. Studies have demonstrated significantly elevated FC levels in patients with CRC, a phenomenon potentially linked to chronic inflammation and immune cell infiltration within the tumor microenvironment. FC exhibits notable advantages in colorectal tumor diagnosis, characterized by high sensitivity and moderate specificity. Emerging research has revealed correlations between FC levels and colorectal tumors staging as well as left-sided versus right-sided tumor localization, with elevated FC levels associated with malignant transformation, local inflammation, and advanced tumor stages (T3 and T4). The diagnostic performance of fecal calprotectin (FC) as a non-invasive marker for colorectal tumors has not yet been established. However, due to its association with inflammation, FC holds promise for playing a more significant role in the screening, staging, and localization of colorectal tumors.https://www.frontiersin.org/articles/10.3389/fmed.2025.1626197/fullfecal calprotectin (FC)colorectal tumorsinflammationdiagnosticnon-invasive biomarkers
spellingShingle Wei Jing
Wei Jing
Jiangshan Sun
Jiangshan Sun
Qingzheng Wu
Xiuli Zhang
Research progress on the diagnostic value of fecal calprotectin in colorectal tumors
Frontiers in Medicine
fecal calprotectin (FC)
colorectal tumors
inflammation
diagnostic
non-invasive biomarkers
title Research progress on the diagnostic value of fecal calprotectin in colorectal tumors
title_full Research progress on the diagnostic value of fecal calprotectin in colorectal tumors
title_fullStr Research progress on the diagnostic value of fecal calprotectin in colorectal tumors
title_full_unstemmed Research progress on the diagnostic value of fecal calprotectin in colorectal tumors
title_short Research progress on the diagnostic value of fecal calprotectin in colorectal tumors
title_sort research progress on the diagnostic value of fecal calprotectin in colorectal tumors
topic fecal calprotectin (FC)
colorectal tumors
inflammation
diagnostic
non-invasive biomarkers
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1626197/full
work_keys_str_mv AT weijing researchprogressonthediagnosticvalueoffecalcalprotectinincolorectaltumors
AT weijing researchprogressonthediagnosticvalueoffecalcalprotectinincolorectaltumors
AT jiangshansun researchprogressonthediagnosticvalueoffecalcalprotectinincolorectaltumors
AT jiangshansun researchprogressonthediagnosticvalueoffecalcalprotectinincolorectaltumors
AT qingzhengwu researchprogressonthediagnosticvalueoffecalcalprotectinincolorectaltumors
AT xiulizhang researchprogressonthediagnosticvalueoffecalcalprotectinincolorectaltumors